Özmert Muhammet Ali Özdemi̇r
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Özmert Muhammet Ali Özdemi̇r has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Hacer Ergin
Pamukkale University Faculty of Medicine, Department of Neonatology, Denizli, Turkey
9 shared publicationsNilay Şen Türk
Department of Pathology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
3 shared publicationsAli Koçyiğit
Departments of Radiology, Pamukkale University Faculty of Medicine, Denizli, Turkey
2 shared publications- Cigdem Yenisey
Department of Biochemistry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
2 shared publications - Ece Koyuncu
Pamukkale Üniversitesi Tıp Fakültesi, Neonatoloji Bilim Dalı
2 shared publications - Hacer Ergi̇n
Pamukkale University, School of Medicine
2 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (5) , 447-449
Novel NALCN Mutation: Fentanyl Sensitivity, Intestinal Atresia, and Hypotonic Infant
- 23 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (5) , 447-449
Open AccessNovel NALCN Mutation: Fentanyl Sensitivity, Intestinal Atresia, and Hypotonic Infant
- 1 October 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- No. Advanced O,p. 1
Surfactant treatment in newborns other than respiratory distress syndrome
Surfactant, a phospholipid mixture, reduces surface tension and keeps the alveoli open. In its deficiency, widespread atelectasis develops and, as a result, ventilation perfusion balance and gas exchange are impaired. Surfactant is produced in lung type II alveolar cells and is mainly used intratracheally in the treatment of respiratory distress syndrome (RDS), a disease of premature babies. However, recently, the use of exogenous surfactant and its potential benefits have also begun to be emphasized in some diseases such as infection (pneumonia), aspiration (meconium) and congenital pulmonary malformation (diaphragmatic hernia) that develop due to secondary surfactant insufficiency, especially in late premature and term babies. In this review, the use of surfactant in non-RDS diseases that cause secondary surfactant deficiency in the lungs in newborn babies, its effectiveness and side effects are discussed with current literature data and guidelines, and scientific recommendations are presented.
- 1 October 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- No. Advanced O,p. 1
Surfactant treatment in newborns other than respiratory distress syndrome
Surfactant, a phospholipid mixture, reduces surface tension and keeps the alveoli open. In its deficiency, widespread atelectasis develops and, as a result, ventilation perfusion balance and gas exchange are impaired. Surfactant is produced in lung type II alveolar cells and is mainly used intratracheally in the treatment of respiratory distress syndrome (RDS), a disease of premature babies. However, recently, the use of exogenous surfactant and its potential benefits have also begun to be emphasized in some diseases such as infection (pneumonia), aspiration (meconium) and congenital pulmonary malformation (diaphragmatic hernia) that develop due to secondary surfactant insufficiency, especially in late premature and term babies. In this review, the use of surfactant in non-RDS diseases that cause secondary surfactant deficiency in the lungs in newborn babies, its effectiveness and side effects are discussed with current literature data and guidelines, and scientific recommendations are presented.
- Open Access
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (4) , 887-898
Clinical process and role of diagnostic tools in hypoxic ischemic encephalopathy: a 5-year retrospective review
Purpose: Hypoxic-ischemic encephalopathy (HIE) is a critical clinical process that leads to permanent/temporary brain damage in newborns due to inadequate oxygenation before, during, or after birth. The present study aimed to evaluate the clinical, radiological, and laboratory results of newborns followed up with the diagnosis of HIE in our neonatal intensive care unit for five years. We also aim to reveal the clinical tools' prognostic importance in HIE. Materials and methods: We retrieved data from the hospital information system for infants who were followed up in Pamukkale University Hospital's neonatal intensive care unit between 2020 and 2025. We drew cord blood at birth and on the 24th day of life for blood gas and biochemistry parameters. We also retrieved the MRI and amplitude EEG results taken within the postnatal 3rd-5th days. Results: During the five years, 58 newborns were followed up with HIE, and 17 were excluded because there was an insufficient patient record. 23 of the patients were male and 18 were female. Follow-up lactate and albumin levels at the 24th hour were found to be related to the neurodevelopmental process. One of the patients died, and three of the survivors developed hearing loss. Conclusion: In our current study, we suggested emphasizing the importance of evaluating HIE with multidisciplinary clinical tools.
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (4) , 887-898
Open AccessClinical process and role of diagnostic tools in hypoxic ischemic encephalopathy: a 5-year retrospective review
Purpose: Hypoxic-ischemic encephalopathy (HIE) is a critical clinical process that leads to permanent/temporary brain damage in newborns due to inadequate oxygenation before, during, or after birth. The present study aimed to evaluate the clinical, radiological, and laboratory results of newborns followed up with the diagnosis of HIE in our neonatal intensive care unit for five years. We also aim to reveal the clinical tools' prognostic importance in HIE. Materials and methods: We retrieved data from the hospital information system for infants who were followed up in Pamukkale University Hospital's neonatal intensive care unit between 2020 and 2025. We drew cord blood at birth and on the 24th day of life for blood gas and biochemistry parameters. We also retrieved the MRI and amplitude EEG results taken within the postnatal 3rd-5th days. Results: During the five years, 58 newborns were followed up with HIE, and 17 were excluded because there was an insufficient patient record. 23 of the patients were male and 18 were female. Follow-up lactate and albumin levels at the 24th hour were found to be related to the neurodevelopmental process. One of the patients died, and three of the survivors developed hearing loss. Conclusion: In our current study, we suggested emphasizing the importance of evaluating HIE with multidisciplinary clinical tools.
- Open Access
- 14 May 2024
- Published by Pamukkale University in Pamukkale Medical Journal
Evaluation of Ema, Töllner and Rodwell scores in the diagnosis of neonatal sepsis
Introduction: There are no specific signs, symptoms and rapid laboratory tests to definitively diagnose sepsis in the neonatal period. This makes it difficult to diagnose sepsis in newborns in a timely manner and initiate appropriate treatment, or causes babies without sepsis to receive unnecessary antibiotics. Purpose: Therefore, in this study, we planned to investigate the clinical adequacy and reliability of EMA (European Medicines Agency), Töllner and Rodwell hematological scoring in the early diagnosis of neonatal sepsis. Method: EMA, Töllner and Rodwell hematological scoring was performed on each patient. Complete blood count, peripheral smear, C-reactive protein, procalcitonin, blood gas and blood sugar values of newborn babies with suspected sepsis were recorded, blood culture, urine culture and cerebrospinal fluid examination and cultures taken when necessary were evaluated. Using statistical analysis, the 'Positive Expected Value and Negative Expected Values' ratios of the scores were obtained, and the performance results were examined. Results: 95 newborns with a preliminary clinical diagnosis of sepsis were included in the study. These babies were divided into two groups: clinical (n:71) and proven sepsis (n:24) according to blood culture results. Positive and negative predictive values of scoring systems in definitive sepsis diagnosis; for EMA respectively; 21.5%, 56.3% for Töllner; It was determined as 31.3%, 77.8%, and 100%, 77.8% for Rodwell. Conclusion: Our study showed that clinician opinion and standard laboratory tests are limited in the diagnosis of neonatal sepsis, and Rodwell hematological scoring is more prominent in recognizing proven sepsis compared to the other two scores .
- 14 May 2024
- Published by Pamukkale University in Pamukkale Medical Journal
Open AccessEvaluation of Ema, Töllner and Rodwell scores in the diagnosis of neonatal sepsis
Introduction: There are no specific signs, symptoms and rapid laboratory tests to definitively diagnose sepsis in the neonatal period. This makes it difficult to diagnose sepsis in newborns in a timely manner and initiate appropriate treatment, or causes babies without sepsis to receive unnecessary antibiotics. Purpose: Therefore, in this study, we planned to investigate the clinical adequacy and reliability of EMA (European Medicines Agency), Töllner and Rodwell hematological scoring in the early diagnosis of neonatal sepsis. Method: EMA, Töllner and Rodwell hematological scoring was performed on each patient. Complete blood count, peripheral smear, C-reactive protein, procalcitonin, blood gas and blood sugar values of newborn babies with suspected sepsis were recorded, blood culture, urine culture and cerebrospinal fluid examination and cultures taken when necessary were evaluated. Using statistical analysis, the 'Positive Expected Value and Negative Expected Values' ratios of the scores were obtained, and the performance results were examined. Results: 95 newborns with a preliminary clinical diagnosis of sepsis were included in the study. These babies were divided into two groups: clinical (n:71) and proven sepsis (n:24) according to blood culture results. Positive and negative predictive values of scoring systems in definitive sepsis diagnosis; for EMA respectively; 21.5%, 56.3% for Töllner; It was determined as 31.3%, 77.8%, and 100%, 77.8% for Rodwell. Conclusion: Our study showed that clinician opinion and standard laboratory tests are limited in the diagnosis of neonatal sepsis, and Rodwell hematological scoring is more prominent in recognizing proven sepsis compared to the other two scores .
- Open Access
- 12 December 2023
- Published by Pamukkale University in Pamukkale Medical Journal
Geçici neonatal diyabetes mellitus
Neonatal diabetes mellitus (NDM) is defined as hyperglycemia in the first six months of life for at least two weeks and requiring insulin therapy. Although its incidence is 1 in 90000-160000 live births, its frequency rises to 1/30000 in societies such as our country where consanguineous marriages are common. NDM may be seen as transient (50-60%), permanent or as a part of syndromes. Clinical manifestations of NDM are intrauterine growth retardation, growth cessation, excessive urination, dehydration, and ketoacidosis. Some of the premature or low birth weight infants may develop hyperglycemia due to many different reasons, so there may be difficulties and delay in diagnosis. If the high blood glucose level lasts longer than 7-10 days after excluding other causes of transient hyperglycemia, it is recommended to suspect NDM and perform genetic examination, especially in infants with blood glucose above 250mg/dL. Herein, a newborn, referred to our neonatal unit due to persistent hyperglycemia on the postnatal 15th day and diagnosed as transient NDM after excluding other causes of hyperglycemia, is presented due to the rarity of the disease.
- 12 December 2023
- Published by Pamukkale University in Pamukkale Medical Journal
Open AccessGeçici neonatal diyabetes mellitus
Neonatal diabetes mellitus (NDM) is defined as hyperglycemia in the first six months of life for at least two weeks and requiring insulin therapy. Although its incidence is 1 in 90000-160000 live births, its frequency rises to 1/30000 in societies such as our country where consanguineous marriages are common. NDM may be seen as transient (50-60%), permanent or as a part of syndromes. Clinical manifestations of NDM are intrauterine growth retardation, growth cessation, excessive urination, dehydration, and ketoacidosis. Some of the premature or low birth weight infants may develop hyperglycemia due to many different reasons, so there may be difficulties and delay in diagnosis. If the high blood glucose level lasts longer than 7-10 days after excluding other causes of transient hyperglycemia, it is recommended to suspect NDM and perform genetic examination, especially in infants with blood glucose above 250mg/dL. Herein, a newborn, referred to our neonatal unit due to persistent hyperglycemia on the postnatal 15th day and diagnosed as transient NDM after excluding other causes of hyperglycemia, is presented due to the rarity of the disease.
- 15 September 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (3) , 271-275
Can the Side Effects of Mydriatics Be Reduced with the ROP-bundle Protocol?
- 15 September 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (3) , 271-275
Can the Side Effects of Mydriatics Be Reduced with the ROP-bundle Protocol?
- Open Access
- 1 January 2023
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Pediatrics
- Vol. 32 (1) , 56-65
Caffeine Therapy in Apnea of Prematurity: Traditional Review
Prematüre apnesi, yenidoğan yoğun bakım ünitelerinde prematüre bebeklerde sıklıkla karşılaşılan bir durum olup, solunumun 15-20 sn'den daha fazla durması ya da daha kısa süreli solunum kesintisine oksijen satürasyon düşüklüğü ve/veya bradikardinin eşlik etmesi olarak tanımlanır. Gebelik haftası 28'in altında doğan bebeklerin hemen tümünde apne görülürken, gebelik haftası büyüdükçe apne sıklığı azalmaktadır. Prematüre doğumun getirdiği nörolojik immatürite ile birlikte apne nedeniyle araya giren hipoksemi ve bradikardi atakları, bu bebeklerde nörolojik hasarlanma riskini artırmakta ve uzun dönemde; serebral palsi, gelişimsel koordinasyon bozukluğu, bilişsel ve davranışsal bozukluklar, bronkopulmoner displazi ve prematüre retinopatisi gibi önemli morbiditelere neden olabilmektedir. Bu nedenle prematüre bebeklerde apne tanısı ve tedavisi önem arz etmekte, apnenin farmakolojik tedavisinde de ilk tercih olarak bir metilksantin türevi olan kafein yer almaktadır. Kafein, yapısal olarak adenozine benzemekte ve etkisi doza bağımlı olarak başlıca adenozin reseptörleri üzerinden olmaktadır. Kafein, prematüre apnesinde adenozin ile baskılanmış medüller solunum merkezi inhibisyonunu ortadan kaldırmakta, gama aminobütirik asit salınımını önleyerek sinirsel uyarılmayı artırmakta, santral sinir sisteminin kan karbondioksit düzeylerine hassasiyeti artırmakta, böylece apneli bebeklerde solunumu uyarmakta ve devamlılığını sağlamaktadır. Bu derlemede, prematüre bebeklerde apne tedavisinde ilk tercih olan kafeinin etkisi, kimlere, ne zaman, hangi dozda ve ne kadar süre kullanmamız gerektiğiyle ilgili bilgiler, son literatür bilgileri ışığında verilmeye çalışılmıştır.
- 1 January 2023
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Pediatrics
- Vol. 32 (1) , 56-65
Open AccessCaffeine Therapy in Apnea of Prematurity: Traditional Review
Prematüre apnesi, yenidoğan yoğun bakım ünitelerinde prematüre bebeklerde sıklıkla karşılaşılan bir durum olup, solunumun 15-20 sn'den daha fazla durması ya da daha kısa süreli solunum kesintisine oksijen satürasyon düşüklüğü ve/veya bradikardinin eşlik etmesi olarak tanımlanır. Gebelik haftası 28'in altında doğan bebeklerin hemen tümünde apne görülürken, gebelik haftası büyüdükçe apne sıklığı azalmaktadır. Prematüre doğumun getirdiği nörolojik immatürite ile birlikte apne nedeniyle araya giren hipoksemi ve bradikardi atakları, bu bebeklerde nörolojik hasarlanma riskini artırmakta ve uzun dönemde; serebral palsi, gelişimsel koordinasyon bozukluğu, bilişsel ve davranışsal bozukluklar, bronkopulmoner displazi ve prematüre retinopatisi gibi önemli morbiditelere neden olabilmektedir. Bu nedenle prematüre bebeklerde apne tanısı ve tedavisi önem arz etmekte, apnenin farmakolojik tedavisinde de ilk tercih olarak bir metilksantin türevi olan kafein yer almaktadır. Kafein, yapısal olarak adenozine benzemekte ve etkisi doza bağımlı olarak başlıca adenozin reseptörleri üzerinden olmaktadır. Kafein, prematüre apnesinde adenozin ile baskılanmış medüller solunum merkezi inhibisyonunu ortadan kaldırmakta, gama aminobütirik asit salınımını önleyerek sinirsel uyarılmayı artırmakta, santral sinir sisteminin kan karbondioksit düzeylerine hassasiyeti artırmakta, böylece apneli bebeklerde solunumu uyarmakta ve devamlılığını sağlamaktadır. Bu derlemede, prematüre bebeklerde apne tedavisinde ilk tercih olan kafeinin etkisi, kimlere, ne zaman, hangi dozda ve ne kadar süre kullanmamız gerektiğiyle ilgili bilgiler, son literatür bilgileri ışığında verilmeye çalışılmıştır.
- Open Access
- 1 December 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (4) , 444-452
Cord Blood Levels of Spexin, Leptin, and Visfatin in Term Infants Born Small, Appropriate, and Large for Gestational Age and Their Association with Newborn Anthropometric Measurements
Children born small for gestational age (SGA) are at risk of future obesity and associated comorbidities. Therefore the identification of risk factors and novel biomarkers which are associated with this risk are needed for early detection and to improve preventive strategies. Spexin (SPX), a novel neuropeptide that is involved in the regulation of obesity and fat metabolism, is a candidate biomarker for predicting obesity and related comorbidities at an early age. The aim of this study was to investigate serum levels of SPX in term infants born small, appropriate, and large for gestational age (LGA) and its association with newborn anthropometric measurements. One hundred and twenty term newborn babies classified as SGA, appropriate for gestational age (AGA), or LGA and their mothers were included. SPX, leptin and visfatin were measured in cord blood and maternal serum by enzyme-linked immunosorbent assay. Fifty-six (46.7%) neonates were girls and 64 (53.3%) were boys. The mean birth weight was 3170.70±663 g, birth length was 48.9±2.79 cm, and head circumference was 34.5±1.67 cm. Birth weights, lengths, and head circumferences of the neonates in the SGA, AGA, and LGA groups were significantly different. Cord blood SPX and leptin levels in the SGA groups were significantly lower than those of both the LGA and AGA groups. Cord blood visfatin levels were significantly lower in the AGA group than the LGA and SGA groups. Maternal SPX levels of SGA babies were significantly lower than those of the mothers in both the LGA and AGA groups, but no significant difference was observed between the SGA and LGA groups. Maternal visfatin levels of the AGA babies were significantly higher than the maternal levels of SGA and LGA groups. There was no difference in terms of maternal leptin levels. Cord blood SPX and leptin levels were positively correlated with birth weight, length and head circumference. Birth weight increased significantly in line with maternal pregestational body mass index. The lowest SPX levels were found in the SGA babies and cord SPX level was significantly correlated with newborn length, weight, and head circumference.
- 1 December 2022
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 14 (4) , 444-452
Open AccessCord Blood Levels of Spexin, Leptin, and Visfatin in Term Infants Born Small, Appropriate, and Large for Gestational Age and Their Association with Newborn Anthropometric Measurements
Children born small for gestational age (SGA) are at risk of future obesity and associated comorbidities. Therefore the identification of risk factors and novel biomarkers which are associated with this risk are needed for early detection and to improve preventive strategies. Spexin (SPX), a novel neuropeptide that is involved in the regulation of obesity and fat metabolism, is a candidate biomarker for predicting obesity and related comorbidities at an early age. The aim of this study was to investigate serum levels of SPX in term infants born small, appropriate, and large for gestational age (LGA) and its association with newborn anthropometric measurements. One hundred and twenty term newborn babies classified as SGA, appropriate for gestational age (AGA), or LGA and their mothers were included. SPX, leptin and visfatin were measured in cord blood and maternal serum by enzyme-linked immunosorbent assay. Fifty-six (46.7%) neonates were girls and 64 (53.3%) were boys. The mean birth weight was 3170.70±663 g, birth length was 48.9±2.79 cm, and head circumference was 34.5±1.67 cm. Birth weights, lengths, and head circumferences of the neonates in the SGA, AGA, and LGA groups were significantly different. Cord blood SPX and leptin levels in the SGA groups were significantly lower than those of both the LGA and AGA groups. Cord blood visfatin levels were significantly lower in the AGA group than the LGA and SGA groups. Maternal SPX levels of SGA babies were significantly lower than those of the mothers in both the LGA and AGA groups, but no significant difference was observed between the SGA and LGA groups. Maternal visfatin levels of the AGA babies were significantly higher than the maternal levels of SGA and LGA groups. There was no difference in terms of maternal leptin levels. Cord blood SPX and leptin levels were positively correlated with birth weight, length and head circumference. Birth weight increased significantly in line with maternal pregestational body mass index. The lowest SPX levels were found in the SGA babies and cord SPX level was significantly correlated with newborn length, weight, and head circumference.
- Open Access
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (4) , 384-390
Vitamin D Deficiency Prevalence in Late Neonatal Hypocalcemia: A Multicenter Study
Objective:Late neonatal hypocalcemia (LNH) is a common metabolic problem associated with hypoparathyroidism, high phosphate intake and vitamin D deficiency, often presenting with seizures. In this cross-sectional study, we aimed to evaluate the role of vitamin D deficiency in LNH in Turkey and to describe the characteristics of affected newborns.Methods:Conducted with a cross-sectional design and with the participation of 61 neonatal centers from December 2015 to December 2016, the study included term neonates with LNH (n=96) and their mothers (n=93). Data were registered on the FAVOR Web Registry System. Serum samples of newborns and mothers were analyzed for calcium, phosphate, magnesium, albumin, alkaline phosphatase, intact parathyroid hormone (iPTH) and 25 hydroxyvitamin D [25(OH)D] levels.Results:The median (range) onset time of hypocalcemia was 5.0 (4.0-8.0) days of age, with a male preponderance (60.4%). The median (range) serum 25(OH)D levels of the neonates and their mothers were 6.3 (4.1-9.05) and 5.2 (4.7-8.8) ng/mL, respectively. The prevalence of vitamin D deficiency (<12 ng/mL) was high in both the neonates (86.5%) and mothers (93%). Serum 25(OH)D levels of the infants and mothers showed a strong correlation (p<0.001). While the majority (93.7%) of the neonates had normal/high phosphorus levels, iPTH levels were low or inappropriately normal in 54.2% of the patients.Conclusion:Vitamin D deficiency prevalence was found to be high in LNH. Efforts to provide vitamin D supplementation during pregnancy should be encouraged. Evaluation of vitamin D status should be included in the workup of LNH.
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (4) , 384-390
Open AccessVitamin D Deficiency Prevalence in Late Neonatal Hypocalcemia: A Multicenter Study
Objective:Late neonatal hypocalcemia (LNH) is a common metabolic problem associated with hypoparathyroidism, high phosphate intake and vitamin D deficiency, often presenting with seizures. In this cross-sectional study, we aimed to evaluate the role of vitamin D deficiency in LNH in Turkey and to describe the characteristics of affected newborns.Methods:Conducted with a cross-sectional design and with the participation of 61 neonatal centers from December 2015 to December 2016, the study included term neonates with LNH (n=96) and their mothers (n=93). Data were registered on the FAVOR Web Registry System. Serum samples of newborns and mothers were analyzed for calcium, phosphate, magnesium, albumin, alkaline phosphatase, intact parathyroid hormone (iPTH) and 25 hydroxyvitamin D [25(OH)D] levels.Results:The median (range) onset time of hypocalcemia was 5.0 (4.0-8.0) days of age, with a male preponderance (60.4%). The median (range) serum 25(OH)D levels of the neonates and their mothers were 6.3 (4.1-9.05) and 5.2 (4.7-8.8) ng/mL, respectively. The prevalence of vitamin D deficiency (<12 ng/mL) was high in both the neonates (86.5%) and mothers (93%). Serum 25(OH)D levels of the infants and mothers showed a strong correlation (p<0.001). While the majority (93.7%) of the neonates had normal/high phosphorus levels, iPTH levels were low or inappropriately normal in 54.2% of the patients.Conclusion:Vitamin D deficiency prevalence was found to be high in LNH. Efforts to provide vitamin D supplementation during pregnancy should be encouraged. Evaluation of vitamin D status should be included in the workup of LNH.
- 1 August 2020
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 7 (2) , 97-100
A Case Report with Spontaneous Pneumomediastinum, Subcutaneous Emphysema and Pneumorrhachis after Viral Infection
- 1 August 2020
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
- Vol. 7 (2) , 97-100
A Case Report with Spontaneous Pneumomediastinum, Subcutaneous Emphysema and Pneumorrhachis after Viral Infection